@elonmusk@JohnStossel@SpaceX@Tesla Elon owns 28% of $TSLA and 46% of $SPCX with a combined value of ~$1.5T. Unheard of in today's market. Would be nice to see more CEOs have this level of commitment
Castle Biosciences founder Derek Maetzold sold $512K of $CSTL on a 10b5-1 plan. Sale #181 on record, against 0 buys.
2019: owned 9.61%. Today: 0.63%.
A founder exit in slow motion, one Form 4 at a time: https://t.co/3IR7JMWIB6
Medpace founder August Troendle just sold $44.4M of $MEDP at his own discretion (not on a plan), with the stock ~2% off its all-time high.
His last buy: Sep 22, 2022, $8.9M, near the low. This sale: Sep 22, 2026. Same date, four years apart.
Still owns 18.51% ($3.2B). https://t.co/ffAxuP2IkG
Her ownership in the company has remained around 1% for years due to this combination of equity compensation and selling stock.
https://t.co/pZerJ6MhZc
$TWST Founder CEO sold 19% of her stake 🚨
On Thursday, 9/17 founder-CEO Emily Leproust reduced her stake in Twist Bioscience by 19%, taking her ownership from 1.23% to 0.99%.
This was part of a 10b5-1 plan adopted on Sept. 5th 2025 which allow for a sale of up to 2,500,000 shares through Novemeber 20, 2026. He has sold approximately 55% of the plans allowance
https://t.co/0YlSWKhkcR